Precision medicine company Natera Inc (NASDAQ: NTRA) on Wednesday announced the presentation of new clinical evidence supporting its...
Whitehawk Therapeutics presents ADC preclinical data at AACR 2026
European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe
Philips secures FDA clearance for Spectral CT Verida system
GSK strengthens pulmonary hypertension pipeline with USD950m acquisition of 35Pharma
hVIVO signs influenza human challenge trial agreement with Traws Pharma
GSK reports strong early-stage data for B7-H4 ADC in gynaecological cancers
FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer
GSK secures China approval for Exdensur to treat nasal polyp condition
Dexcel Pharma's Nintedanib Capsules approved for US launch
Gilead to acquire Tubulis to expand ADC oncology capabilities